| PERIOD ENDING | 2-May-09 | 31-Jan-09 | 1-Nov-08 | 2-Aug-08 | | Total Revenue | 1,505,296 | 2,082,284 | 1,546,056 | 1,646,502 | | Cost of Revenue | 979,579 | 1,533,673 | 1,046,428 | 1,129,366 | | | Gross Profit | 525,717 | 548,611 | 499,628 | 517,136 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 428,784 | 499,185 | 504,660 | 493,770 | | Non Recurring | (68) | 178,634 | 1,988 | (8,093) | | Others | 65,524 | 72,074 | 67,117 | 73,021 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 31,477 | (201,282) | (74,137) | (41,562) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (9,335) |
-
|
-
| | Earnings Before Interest And Taxes | 31,477 | (210,617) | (74,137) | (41,562) | | Interest Expense | 18,408 | 12,347 | 22,000 | 23,026 | | Income Before Tax | 13,069 | (222,964) | (96,137) | (64,588) | | Income Tax Expense | 4,650 | (75,970) | (38,900) | (27,260) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,663 | (149,348) | (56,070) | (38,340) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 7,663 | (149,348) | (56,070) | (38,340) | | Preferred Stock And Other Adjustments |
-
|
-
| 6,022 | (6,022) | | | Net Income Applicable To Common Shares | $7,663 | ($149,348) | ($50,048) | ($44,362) |
|
0.45% Nasdaq 
0.20%
Income Statement
